Patient factors influencing the selection Of glucose-lowering ...
409
Description

Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and CKD. 



AGI,alpha-glucosidase inhibitor: 

ASCVD. atherosclerotic cardiovascular disease: 

CKD. chronic kidney disease,

DPP4i, dipeptidyl peptidase—4 inhibitor,

eGFR. estimated glomerular filtration rate 

GLP IRA. glucagon-like peptide- I receptor agonist

SGLT2i. sodium-glucose cotransporter-2 inhibitor;

SU, sulfonylurea; T2D. type 2 diabetes; TZD, thiazolidinedione.

type 2 diabetes; TZD,

#KDIGO2020 #CKD #Diabetes Management in CKD #management #treatment #CHART
Contributed by

Medical jobs
view all

0 Comments

Related content